{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:14:42Z","timestamp":1790856882202,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd007443","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2011,12,7]],"date-time":"2011-12-07T00:00:00Z","timestamp":1323216000000}}],"reference-count":30,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007443.pub2","type":"journal-article","created":{"date-parts":[[2011,12,5]],"date-time":"2011-12-05T21:33:04Z","timestamp":1323120784000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["Probiotics for maintenance of remission in ulcerative colitis"],"prefix":"10.1002","author":[{"given":"Khimara","family":"Naidoo","sequence":"first","affiliation":[{"name":"Guys and St Thomas' NHS Foundation Trust; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morris","family":"Gordon","sequence":"additional","affiliation":[{"name":"Royal Manchester Children's Hospital; Oxford Road Manchester UK M13 9WL"},{"name":"University of Salford; Faculty of Health and Social Care; Salford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew O","family":"Fagbemi","sequence":"additional","affiliation":[{"name":"Booth Hall Children's Hospital; Department of Paediatric Gastroenterology; Charlestown Road, Blackley Manchester UK M9 7AA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian G","family":"Thomas","sequence":"additional","affiliation":[{"name":"Royal Manchester Children's Hospital; Oxford Road Manchester UK M13 9WL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony K","family":"Akobeng","sequence":"additional","affiliation":[{"name":"Royal Manchester Children's Hospital; Oxford Road Manchester UK M13 9WL"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,12,7]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD007443.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1046\/j.1365-2036.1997.00225.x","article-title":"Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis","volume":"11","author":"Kruis","year":"1997","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"11","key":"10.1002\/14651858.CD007443.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1136\/gut.2003.037747","article-title":"Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine","volume":"53","author":"Kruis","year":"2004","journal-title":"Gut"},{"issue":"2","key":"10.1002\/14651858.CD007443.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.crohns.2010.11.004","article-title":"A randomised double-blind placebo-controlled trial with Lactobacillus acidophilus La-5 and Bifidobacterium animalis subsp. lactis BB-12 for maintenance of remission in ulcerative colitis","volume":"5","author":"Wildt","year":"2011","journal-title":"Journal of Crohn's and Colitis"},{"issue":"11","key":"10.1002\/14651858.CD007443.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1111\/j.1365-2036.2006.02927.x","article-title":"Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis","volume":"23","author":"Zocco","year":"2006","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"10","key":"10.1002\/14651858.CD007443.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.3748\/wjg.v10.i10.1521","article-title":"Effects of probiotics on intestinal mucosa of patients with ulcerative colitis","volume":"10","author":"Cui","year":"2004","journal-title":"World Journal of Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD007443.pub2-BIB0006|cit6","first-page":"547","article-title":"Probiotics for the prevention of ulcerative colitis recurrence: an alternative medicine to standard treatment?","volume":"38","author":"Folwaczny","year":"2000","journal-title":"Zeitschrift f\u00fcr Gastroenterologie"},{"issue":"5","key":"10.1002\/14651858.CD007443.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.nut.2008.11.017","article-title":"Randomized controlled trial on the efficacy of synbiotic versus probiotic or prebiotic treatment to improve the quality of life in patients with ulcerative colitis","volume":"25","author":"Fujimori","year":"2009","journal-title":"Nutrition"},{"issue":"9","key":"10.1002\/14651858.CD007443.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1055\/s-2008-1027463","article-title":"Probiotic Escherichia coli Nissle 1917 (EcN) for successful remission maintenance of ulcerative colitis in children and adolescents: an open-label pilot study","volume":"46","author":"Henker","year":"2008","journal-title":"Zeitschrift fur Gastroenterologie"},{"issue":"1","key":"10.1002\/14651858.CD007443.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1080\/07315724.2003.10719276","article-title":"Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis","volume":"22","author":"Ishikawa","year":"2002","journal-title":"Journal of the American College of Nutrition"},{"issue":"2","key":"10.1002\/14651858.CD007443.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/ajg.2008.118","article-title":"Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis","volume":"104","author":"Miele","year":"2009","journal-title":"American Journal of Gastroenterology"},{"issue":"9179","key":"10.1002\/14651858.CD007443.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(98)06343-0","article-title":"Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial","volume":"354","author":"Rembacken","year":"1999","journal-title":"Lancet"},{"issue":"4 Suppl 2","key":"10.1002\/14651858.CD007443.pub2-BIB0012|cit12","first-page":"A44","article-title":"A one year, randomised, double-blind, placebo controlled trial of a Lactobacillus or a Bidifobacterium probiotic for maintenance of steroid-induced remission of ulcerative colitis","volume":"130","author":"Shanahan","year":"2006","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1002\/14651858.CD007443.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1080\/00365520701396091","article-title":"Clinical effectiveness of probiotics therapy (BIO-THREE) in patients with ulcerative colitis refractory to conventional therapy","volume":"42","author":"Tsuda","year":"2007","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"8","key":"10.1002\/14651858.CD007443.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1046\/j.1365-2036.1999.00560.x","article-title":"Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis","volume":"13","author":"Venturi","year":"1999","journal-title":"Alimentary Pharmacology and Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD007443.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1136\/gut.52.3.370","article-title":"Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment","volume":"52","author":"Dieleman","year":"2003","journal-title":"Gut"},{"issue":"2","key":"10.1002\/14651858.CD007443.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3109\/00365529309096063","article-title":"The effect of exogenous administration of Lactobacillus reuteri R2LC and oat fiber on acetic-induced colitis in the rat","volume":"28","author":"Fabia","year":"1993","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"6","key":"10.1002\/14651858.CD007443.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1053\/j.gastro.2004.02.071","article-title":"Medical therapy for ulcerative colitis 2004","volume":"126","author":"Hanauer","year":"2004","journal-title":"Gastroenterology"},{"issue":"7414","key":"10.1002\/14651858.CD007443.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD007443.pub2-BIB0019|cit19","article-title":"Chapter 8: Assessing risk of bias in included studies","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]","author":"Higgins","year":"2011. Available from www.cochrane-handbook.org"},{"issue":"12","key":"10.1002\/14651858.CD007443.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1080\/003655200453601","article-title":"Probiotic therapy fails to improve gut permeability in a hapten model of colitis","volume":"35","author":"Kennedy","year":"2000","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"5","key":"10.1002\/14651858.CD007443.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0016-5085(99)70013-2","article-title":"Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice","volume":"116","author":"Madsen","year":"1999","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1002\/14651858.CD007443.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1053\/gast.2001.27224","article-title":"Probiotic bacteria enhance murine and human intestinal epithelial barrier function","volume":"121","author":"Madsen","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1002\/14651858.CD007443.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1001\/jama.281.12.1110","article-title":"Accuracy of data in abstracts of published research articles","volume":"281","author":"Pitkin","year":"1999","journal-title":"JAMA"},{"issue":"23","key":"10.1002\/14651858.CD007443.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1056\/NEJMoa050516","article-title":"Infliximab for induction and maintenance therapy for ulcerative colitis","volume":"353","author":"Rutgeerts","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD007443.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1053\/j.gastro.2004.03.024","article-title":"Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics and prebiotics","volume":"126","author":"Sartor","year":"2004","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD007443.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00054725-200203000-00001","article-title":"Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice","volume":"8","author":"Schultz","year":"2002","journal-title":"Inflammatory Bowel Diseases"},{"issue":"6","key":"10.1002\/14651858.CD007443.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00054725-200211000-00004","article-title":"Variable response to probiotics in two models of experimental colitis in rats","volume":"8","author":"Shibolet","year":"2002","journal-title":"Inflammatory Bowel Diseases"},{"issue":"2 10.1002\/14651","key":"10.1002\/14651858.CD007443.pub2-BIB0028|cit28","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000544.pub2","article-title":"Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis","author":"Sutherland","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD007443.pub2-BIB0029|cit29","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000478.pub2","article-title":"Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis","author":"Timmer","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD007443.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/gut.43.1.29","article-title":"A simple clinical colitis activity index","volume":"43","author":"Walmsley","year":"1998","journal-title":"Gut"}],"updated-by":[{"DOI":"10.1002\/14651858.cd007443.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T00:00:00Z","timestamp":1583280000000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD007443.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T22:10:22Z","timestamp":1628547022000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD007443.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane IBD Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,12,7]]},"references-count":30,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007443.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD007443.pub3","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,7]]}}}